West Pharmaceutical Services Inc (BSP:W2ST34)
R$ 55.16 0.16 (0.29%) Market Cap: 139.83 Bil Enterprise Value: 138.71 Bil PE Ratio: 48.32 PB Ratio: 8.58 GF Score: 89/100

Q4 2023 West Pharmaceutical Services Inc Earnings Call Transcript

Feb 15, 2024 / 02:00PM GMT
Release Date Price: R$49.35
Operator

Thank you for standing by, and welcome to West Pharmaceutical Services Fourth Quarter 2023 Earnings Conference Call. (Operator Instructions)

I would now like to hand the call over to Vice President, Strategy and Investor Relations, Quintin Lai. Please go ahead.

Quintin J. Lai
West Pharmaceutical Services, Inc. - VP of Strategy & IR

Thank you, Latif. Good morning, and welcome to West's Fourth Quarter and Full Year 2023 Conference Call. We issued our financial results this morning, and the release has been posted in the Investors section on the company's website located at westpharma.com.

This morning, we will review our financial results, provide an update on our business and provide -- present an update on our financial outlook for the full year 2024. There's a slide presentation that accompanies today's call, and a copy of the presentation is available on the Investors section of our website.

On Slide 4 is our safe harbor statement. Statements made by management on this call and in the accompanying presentation contain forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot